Improved personalized treatment through "organ-on-a-chip" technology

From top left: Steven Ray Wilson, Carl Henrik Gørbitz, Stefan Krauss and Hanne Scholz
From top left: Steven Ray Wilson, Carl Henrik Gørbitz, Stefan Krauss and Hanne Scholz

Oslo University hospital scientists are involved in developing a novel "organ-on-a-chip" technology for advanced drug testing, that may lead to improved personalized treatment. This project is broadly presented in a recent feature article in the major newspaper Aftenposten, entitled "Drug testing on mini-organs can reduce the use of laboratory animals", written by Steven RAy Wilsen (UiO), Carl Henrik Gørbitz (UiO), Stefan Krauss (Dept. of Immunology, OUS and UiO) and Hanne Scholz (Dept. of Transplantation Medicine, OUS and UiO).

Links:

The Aftenposten article (in Norwegian):
Legemiddeltesting på mini-organer kan redusere bruk av forsøksdyr


The Experimental Cell Transplantation Research Group, led by Hanne Scholz

The Cell Signalling Research Group, led by Stefan Krauss

Department of Transplantation Medicine

Department of Immunology

 
Page visits: 333